Tango Therapeutics, Inc.TNGXNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank83
3Y CAGR+7.7%
5Y CAGR+21.5%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+7.7%/yr
Annual compound
5Y CAGR
+21.5%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
2.6x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
2025$132.16M-8.2%
2024$143.92M+24.9%
2023$115.20M+8.8%
2022$105.91M+36.4%
2021$77.64M+55.3%
2020$49.99M+54.9%
2019$32.27M-